POCARED Diagnostics
PrivateLast Round
Debt
May 12, 2022
Est. Valuation
$23M
Total Funding Raised
$89.46M
Company Overview
POCARED Diagnostics is a health tech company that develops in-vitro diagnostic platforms for rapid, real-time testing of infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Medical AI, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
POCARED Diagnostics Comparables
Compare POCARED Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SeLux Diagnostics | 79% | |
| Neomend | 77% | |
| Accelerate Diagnostics Inc | 77% |
For institutional investors. Book with your work email.
POCARED Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | May 12, 2022 | ||||
| Debt | Dec 21, 2021 | ||||
| Strategic | Jul 1, 2021 | ||||
| Early Funding | Feb 17, 2015 | ||||
| Convertible Debt | Mar 1, 2008 | ||||
Series D | Jun 12, 2007 |
For institutional investors. Book with your work email.
POCARED Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Investment Bank Group | Debt |
| Elron Ventures | Convertible Debt, Series D |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 21, 2021
$25M round led by European Investment Bank Group
- Jul 1, 2021
$50M round led by gemny
For institutional investors. Book with your work email.
POCARED Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about POCARED Diagnostics's valuation, stock price, and market status.
Is POCARED Diagnostics a public or private company?
POCARED Diagnostics is a private company.
What is the current stock price of POCARED Diagnostics?
POCARED Diagnostics is a private company, so its shares have no public market price. Caplight tracks POCARED Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is POCARED Diagnostics worth (valuation)?
POCARED Diagnostics's valuation is estimated at $23.0M based on funding round data.
Can I buy POCARED Diagnostics stock?
POCARED Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was POCARED Diagnostics's last funding round?
POCARED Diagnostics's most recent funding round was Debt on May 12, 2022.
Who are the main investors in POCARED Diagnostics?
Key investors in POCARED Diagnostics include European Investment Bank Group, Elron Ventures.
Will POCARED Diagnostics IPO soon?
No public IPO plans have been announced for POCARED Diagnostics.
How can I track POCARED Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in POCARED Diagnostics's shares on secondary markets.